Metabolic and Metabo-Clinical Signatures of Type 2 Diabetes, Obesity, Retinopathy, and Dyslipidemia.

MLA

Yousri, Noha A., et al. “Metabolic and Metabo-Clinical Signatures of Type 2 Diabetes, Obesity, Retinopathy, and Dyslipidemia.” Diabetes, vol. 71, no. 2, Feb. 2022, pp. 184–205. EBSCOhost, https://doi.org/10.2337/db21-0490.

APA

Yousri, N. A., Suhre, K., Yassin, E., Al-Shakaki, A., Robay, A., Elshafei, M., Chidiac, O., Hunt, S. C., Crystal, R. G., & Fakhro, K. A. (2022). Metabolic and Metabo-Clinical Signatures of Type 2 Diabetes, Obesity, Retinopathy, and Dyslipidemia. Diabetes, 71(2), 184–205. https://doi.org/10.2337/db21-0490

Chicago

Yousri, Noha A, Karsten Suhre, Esraa Yassin, Alya Al-Shakaki, Amal Robay, Maha Elshafei, Omar Chidiac, Steven C Hunt, Ronald G Crystal, and Khalid A Fakhro. 2022. “Metabolic and Metabo-Clinical Signatures of Type 2 Diabetes, Obesity, Retinopathy, and Dyslipidemia.” Diabetes 71 (2): 184–205. doi:10.2337/db21-0490.